Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Pathophysiology of Gouty Tophi

Lara C. Pullen, PhD  |  Issue: April 2018  |  March 19, 2018

The researchers also found that MSU-induced NETosis was not reduced by inhibitors of necroptosis, nor was it inhibited by therapeutic agents used to treat gout, such as colchicine, indomethacin and dexamethasone. Thus, they established that MSU crystal-induced NETs are less susceptible to DNase 1 and serum degradation than were PMA-NETs. In other words, the MSU-NETs were functionally distinct from PMA-NETs because they exhibited resistance to DNase and serum degradation. Although the full consequences of MSU-induced NETosis remain unclear, the authors hypothesize in their paper that the inappropriate NETosis promotes or perpetuates inflammation.


Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Chatfield SM, Grebe K, Whitehead LW, et al. Monosodium urate crystals generate nuclease-resistant neutrophil extracellular traps via a distinct molecular pathway. J Immunol. 2018 Mar 1;200(5):1802–1816. doi: 10.4049/jimmunol.1701382. Epub 2018 Jan 24.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:Goutmonosodium urate crystalsNETosisneutrophils

Related Articles

    Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity

    January 19, 2016

    SAN FRANCISCO—To unravel the mysteries of how autoimmunity begins in the body and, one day, to interrupt that process, rheumatology researchers are exploring the role of neutrophils, especially when they form and release neutrophil extracellular traps (NETs). At a panel discussion on Nov. 6, 2015, held at the American College of Rheumatology’s Basic Research Conference,…

    Clinical Applications of Dual-Energy Computed Tomography for Rheumatology

    June 1, 2014

    Advanced imaging technique allows physicians to detect deposition of monosodium urate crystals not apparent in physical exams and better diagnose gout

    Neutrophil Extracellular Traps & Their Role in Autoimmunity

    May 18, 2018

    Certain medications have been associated for decades with the development of drug-induced autoimmunity. New research published in March 2018 in Arthritis & Rheumatology suggests that NETs (neutro­phil extracellular traps) are potentially implicated in the mechanisms that lead to drug-induced autoimmunity.1 Peter Grayson, MD, MSc, head of the Vasculitis Translational Research Program at the National Institute…

    Aggregated Neutrophils Limit Inflammation

    June 30, 2014

    A new study suggests understanding this antiinflammatory pathway may lead to new immunomodulatory therapy for resolving inflammation

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences